BioImagene collaborates with 10 new academic medical centers to build up digital pathology solutions BioImagene, Inc., the leading supplier of innovative digital pathology solutions provides added ten new educational medical centers to it is roster of collaborators over the last quarter. Several collaborators have already been named America’s Greatest Hospitals 2010-2011: The Honor Roll by U.S. World and News Record. Both these characteristics are necessary for broad-structured adoption of digital pathology. Related StoriesDrug compounds focus on multiple pathways connected with myotonic dystrophy type 1Specific gut bacterias can improve cancers immunotherapy, show studiesGenetic reduced amount of AMPK enzyme can prevent or delay hearing lossThe scope of the collaborations between experts and clinicians from these leading educational medical establishments and BioImagene consist of co-development of brand-new Companion Algorithms for Companion Diagnostics for breasts, prostate, lung, gastro-intestinal and liver cancer tumor, and validation of integrated diagnostic workstations to be utilized by pathologists in scientific practice.The findings may help our future capability to immediate coronary angiography to the patients with real clinical want. With Corus CAD, clinicians have an entirely new now, convenient and safe way to assess the presence of obstructive coronary artery disease, said John McPherson, M.D., assistant professor of Medicine, Division of Cardiovascular Medicine at Vanderbilt Center and Vascular Institute in Nashville, Tennessee, who served as an investigator for the trial. Corus CAD is becoming an invaluable tool in my daily practice, offering complementary details to clinical elements and assisting me better non-invasively evaluate whether a patient’s symptoms are due to obstructive coronary artery disease. The test could be easily administered in virtually any practice setting – I take advantage of it both in our urban educational practice and in outlying rural treatment centers.